title: Palliative care opportunities for women with advanced ovarian cancer associated with intraperitoneal chemotherapy.
abstract: Intraperitoneal chemotherapy poses both potential benefits as a cancer treatment and negative consequences on patient and family quality of life. The profound multi-dimensional quality of life impact of intraperitoneal (IP) chemotherapy upon women with advanced ovarian cancer makes the early integration of palliative care particularly important for this population. Numerous opportunities occur throughout the treatment process to improve the delivery of biopsychosocial-spiritual support to women receiving IP chemotherapy.
authors.affiliation: City of Hope, Duarte, California 91010-3000, USA. Sotis-green@coh.org
authors.forename: Shirley
authors.initials: S
authors.lastname: Otis-Green
authors.forename: Mark T
authors.initials: MT
authors.lastname: Wakabayashi
authors.forename: Robert
authors.initials: R
authors.lastname: Morgan
authors.forename: Amy
authors.initials: A
authors.lastname: Hakim
authors.forename: Betty
authors.initials: B
authors.lastname: Ferrell
authors.forename: Virginia
authors.initials: V
authors.lastname: Sun
authors.forename: Eunice
authors.initials: E
authors.lastname: Yang
authors.forename: Marcia
authors.initials: M
authors.lastname: Grant
mesh_terms: D000368:Aged; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000008:administration & dosage / Q000009:adverse effects*; D002140:California; D002945:Cisplatin / Q000008:administration & dosage / Q000009:adverse effects; D005260:Female; D006801:Humans; D007263:Infusions, Parenteral; D008875:Middle Aged; D033262:Narration; D010051:Ovarian Neoplasms / Q000150:complications / Q000188:drug therapy / Q000523:psychology / Q000628:therapy*; D017239:Paclitaxel / Q000008:administration & dosage / Q000009:adverse effects; D010166:Palliative Care; D036301:Qualitative Research; D011788:Quality of Life; D012189:Retrospective Studies
chemical_list: D017239:Paclitaxel; D002945:Cisplatin